SIGN UP
LOG IN
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Benzinga·01/28/2025 10:06:08
Listen to the news
Shares of IMAC Holdings, Inc. (NASDAQ:BACK) rose sharply in today's pre-market trading after the company announced it launched Ignite Proteomics, its new subsidiary.
IMAC shares jumped 108.6% to $1.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Dunxin Financial Holdings (NYSE:DXF) gained 110.6% to $16.32 in pre-market trading after dipping 73% on Monday.
- Planet Image International Limited (NASDAQ:YIBO) rose 85.7% to $5.72 in pre-market trading following a 43% surge on Monday.
- ZK International Group Co., Ltd. (NASDAQ:ZKIN) gained 47% to $0.9998 in pre-market trading after the company reported a year-over-year increase in FY24 EPS results.
- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) gained 32.7% to $0.2191 in pre-market trading after falling 13% on Monday. Hepion Pharmaceuticals recently announced a $9 million public offering.
- Pulmonx Corporation (NASDAQ:LUNG) gained 27.2% to $8.00 in pre-market trading.
- JIADE Limited (NASDAQ:JDZG) rose 26.1% to $1.11 in pre-market trading after gaining around 18% on Monday.
- Unity Bancorp, Inc. (NASDAQ:UNTY) gained 23.7% to $59.99 in pre-market trading.
- Concentra Group Holdings Parent, Inc. (NYSE:CON) shares jumped 14.6% to $26.99 in pre-market trading. Concentra recently announced a 5.5% increase in preliminary fourth-quarter 2024 revenue.
- Empire Petroleum Corporation (NYSE:EP) rose 8.2% to $6.50 in pre-market trading.
Losers
- Evergreen Corporation (NASDAQ:EVGR) shares fell 58.3% to $5.00 in pre-market trading.
- Greenlight Capital Re, Ltd (NASDAQ:GLRE) shares fell 49.1% to $7.00 in pre-market trading.
- Actuate Therapeutics, Inc. (NASDAQ:ACTU) dipped 41.1% to $6.00 in pre-market trading.
- Prothena Corporation plc (NASDAQ:PRTA) declined 31.4% to $11.01 in pre-market trading.
- The Joint Corp. (NASDAQ:JYNT) fell 27.3% to $8.10 in today's pre-market trading. The Joint Corp recently announced a year-over-year increase in patient visits.
- Varex Imaging Corporation (NASDAQ:VREX) shares dipped 26% to $10.10 in pre-market trading. Varex Imaging will report unaudited financial results for the first quarter of fiscal year 2025 on Thursday, Feb. 6.
- Champions Oncology, Inc. (NASDAQ:CSBR) fell 22.2% to $9.10 in pre-market trading.
- EVI Industries, Inc. (NYSE:EVI) shares tumbled 13.1% to $16.20 in pre-market trading. EVI Industries recently announced plans to acquire Haiges Machinery.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) fell 13% to $37.00 in pre-market trading.
- Alvotech (NASDAQ:ALVO) fell 9.6% to $11.81 in pre-market trading.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.